Dan Lu - Distinguished Scientist Development Modeling & Simulation, Development Sciences

Dan Lu

Distinguished Scientist Development Modeling & Simulation, Development Sciences

"I aim to deliver the right dose to the right patient by applying modeling and simulation approaches"
15
Years at Genentech
48
Publications at Genentech

I joined Genentech in March of 2009 after 2 years of work at Roche Palo Alto preclinical modeling and simulation group. Since joining Genentech, I have worked on both clinical pharmacology and modeling & simulation aspects to support drug development, mainly in the field of monoclonal antibodies and antibody drug conjugates for cancer treatment.

Featured Publication

Time-to-Event Analysis of Polatuzumab Vedotin-Induced Peripheral Neuropathy to Assist in the Comparison of Clinical Dosing Regimens.

CPT:PSP, CPT Pharmacometrics Syst Pharmacol. 2017 Jun;6(6):401-408.

Lu D, Gillespie WR, Girish S, Agarwal P, Li C, Hirata J, Chu YW, Kagedal M, Leon L, Maiya V, Jin JY.